SKI Market

A+| A| A-|

Indian Indices

Sensex

73,983.18 64.42
( 0.09%)

Global Indices

Nasdaq

50,884.98 77.97
(0.15%)

Dow Jones

7,407.31 -19.42
(-0.26%)

Hang Seng

64,234.22 -1,182.41
(-1.81%)

Nikkei 225

10,242.24 -130.96
(-1.26%)

Forex

USD-INR

95.53 0.30
(0.32%)

EUR-INR

110.14 0.47
(0.43%)

GBP-INR

127.43 0.45
(0.36%)

JPY-INR

0.60 0.00
(0.41%)

YOU ARE HERE :
HOME
Markets
Equity
Company News

EQUITY - MARKET SCREENER

Alkem Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

539523

INE540L01014

1170.8077615

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ALKEM

27.78

63997.76

EPS(TTM)

Face Value()

Div & Yield %

192.67

0.99

Date	Headline
05-Jun-2026	Alkem Laboratories to conduct AGM
02-Jun-2026	Alkem launches semaglutide in ready-to-use single-shot pre-filled syringes
29-May-2026	Stock Alert: Alkem Lab, PC Jeweller, PG Electroplast, Gulf Oil Lubricants, Axicades Tech
29-May-2026	Alkem Lab gains after Q4 PAT slumps 25% YoY to Rs 251 cr
28-May-2026	Board of Alkem Laboratories recommends final dividend
28-May-2026	Alkem Laboratories consolidated net profit declines 22.69% in the March 2026 quarter
28-May-2026	Alkem Lab Q4 PAT slumps 25% YoY to Rs 251 cr
20-May-2026	Alkem Laboratories announces board meeting date
18-May-2026	Alkem Laboratories announces change in senior management
08-May-2026	Alkem's CRO facility clears USFDA inspection

<< < 1 2 3 ... > >>

73,983.18 64.42 ( 0.09%)

50,884.98 77.97 (0.15%)

7,407.31 -19.42 (-0.26%)

64,234.22 -1,182.41 (-1.81%)

10,242.24 -130.96 (-1.26%)

95.53 0.30 (0.32%)

110.14 0.47 (0.43%)

127.43 0.45 (0.36%)

0.60 0.00 (0.41%)